• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤诱导性骨软化症中生长抑素受体显像的图文综述:单机构经验

A Pictorial Essay of Somatostatin Receptor Imaging in Tumor-Induced Osteomalacia: A Single Institutional Experience.

作者信息

Luthra Karuna, Gauthaman Dinesh Kumar, Lele Vikram

机构信息

Department of Nuclear Medicine and PET-CT, Jaslok Hospital and Research Centre, Mumbai, Maharashtra, India.

出版信息

Indian J Nucl Med. 2022 Jan-Mar;37(1):83-90. doi: 10.4103/ijnm.ijnm_101_21. Epub 2022 Mar 25.

DOI:10.4103/ijnm.ijnm_101_21
PMID:35478669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9037871/
Abstract

Tumor-induced osteomalacia (TIO) is a rare cause of severe debilitating osteomalacia, due to hypophosphatemia. A strong clinical suspicion based on biochemical parameters can lead to the search for a culprit tumor in the body. The disease entity is more commonly caused by benign mesenchymal tumors. While many imaging modalities have been tried, it is now known that these tumors show high somatostatin receptor (SSTR) expression. Hence SSTR receptor imaging has emerged as a useful diagnostic tool. Here we present a series of TIO cases with clinical presentation and imaging characteristics.

摘要

肿瘤诱导的骨软化症(TIO)是严重致残性骨软化症的罕见病因,由低磷血症引起。基于生化参数的强烈临床怀疑可促使在体内寻找致病肿瘤。该疾病实体更常见于良性间充质肿瘤。虽然已经尝试了许多成像方式,但现在已知这些肿瘤显示出高生长抑素受体(SSTR)表达。因此,SSTR受体成像已成为一种有用的诊断工具。在此,我们展示了一系列具有临床表现和影像学特征的TIO病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/36d1cf659c07/IJNM-37-83-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/90daa95385cf/IJNM-37-83-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/6d3c00d24f31/IJNM-37-83-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/6d3c0b4fe853/IJNM-37-83-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/5fa4c8404d9a/IJNM-37-83-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/d5b4e42894c4/IJNM-37-83-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/c8b9252da5ec/IJNM-37-83-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/d2210c408ce2/IJNM-37-83-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/36d1cf659c07/IJNM-37-83-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/90daa95385cf/IJNM-37-83-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/6d3c00d24f31/IJNM-37-83-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/6d3c0b4fe853/IJNM-37-83-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/5fa4c8404d9a/IJNM-37-83-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/d5b4e42894c4/IJNM-37-83-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/c8b9252da5ec/IJNM-37-83-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/d2210c408ce2/IJNM-37-83-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3149/9037871/36d1cf659c07/IJNM-37-83-g008.jpg

相似文献

1
A Pictorial Essay of Somatostatin Receptor Imaging in Tumor-Induced Osteomalacia: A Single Institutional Experience.肿瘤诱导性骨软化症中生长抑素受体显像的图文综述:单机构经验
Indian J Nucl Med. 2022 Jan-Mar;37(1):83-90. doi: 10.4103/ijnm.ijnm_101_21. Epub 2022 Mar 25.
2
Detection Rate of Culprit Tumors Causing Osteomalacia Using Somatostatin Receptor PET/CT: Systematic Review and Meta-Analysis.使用生长抑素受体PET/CT检测导致骨软化症的罪魁祸首肿瘤的检出率:系统评价和荟萃分析
Diagnostics (Basel). 2019 Dec 18;10(1):2. doi: 10.3390/diagnostics10010002.
3
Pindborg Tumor-An Uncommon Odontogenic Tumor Detected by 68Ga-DOTATOC.平博瑞格瘤——一种通过68Ga-DOTATOC检测出的罕见牙源性肿瘤。
Diagnostics (Basel). 2022 Feb 2;12(2):389. doi: 10.3390/diagnostics12020389.
4
Tumour-induced osteomalacia: a literature review and a case report.肿瘤诱导的骨软化症:文献综述与病例报告
World J Surg Oncol. 2016 Jan 8;14(1):4. doi: 10.1186/s12957-015-0763-7.
5
68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.68Ga DOTA-TATE PET/CT能够在肿瘤诱导的骨软化症患者中定位肿瘤,而这些患者的111In-奥曲肽SPECT/CT检查结果为阴性。
Bone. 2014 Jul;64:222-7. doi: 10.1016/j.bone.2014.04.016. Epub 2014 Apr 24.
6
Tumor-induced osteomalacia: experience from a South American academic center.肿瘤相关性骨软化症:来自一家南美学术中心的经验。
Osteoporos Int. 2017 Jul;28(7):2187-2193. doi: 10.1007/s00198-017-4007-2. Epub 2017 Mar 25.
7
Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.肿瘤相关性骨软化症治愈性手术后的低磷血症和重症监护时间延长:一例报告。
Front Endocrinol (Lausanne). 2021 Jun 3;12:686135. doi: 10.3389/fendo.2021.686135. eCollection 2021.
8
Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.肿瘤诱导的骨软化症——一种超越疼痛、抑郁的神秘疾病。
Endocr Regul. 2021 Sep 13;55(3):163-168. doi: 10.2478/enr-2021-0017.
9
A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.一例罕见的沿腱鞘多发磷尿性间叶肿瘤致骨软化症病例。
BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.
10
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.

引用本文的文献

1
Tumour-Induced Osteomalacia-A Long Way to the Diagnosis Facilitated by [Ga]Ga-DOTATATE PET/CT.肿瘤诱导的骨软化症——[镓]镓- DOTATATE PET/CT助力漫长的诊断之路
J Clin Med. 2024 Mar 21;13(6):1817. doi: 10.3390/jcm13061817.
2
Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome.枕骨和肿瘤相关性骨软化症:一种罕见副肿瘤综合征的罕见肿瘤部位。
Arch Osteoporos. 2023 Jul 12;18(1):94. doi: 10.1007/s11657-023-01305-y.
3
Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.

本文引用的文献

1
Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.鼻-鼻窦磷酸盐尿性间叶性肿瘤的多种表现:病例系列报告并随访。
Eur Arch Otorhinolaryngol. 2019 Jun;276(6):1677-1684. doi: 10.1007/s00405-019-05341-8. Epub 2019 Mar 16.
2
Tumor-induced osteomalacia: experience from three tertiary care centers in India.肿瘤诱导的骨软化症:来自印度三个三级医疗中心的经验。
Endocr Connect. 2019 Mar;8(3):266-276. doi: 10.1530/EC-18-0552.
3
Phosphaturic mesenchymal tumor of the nasal cavity and paranasal sinuses: A clinical curiosity presenting a diagnostic challenge.
肿瘤相关性骨软化症的识别、诊断和管理全球指南。
J Intern Med. 2023 Mar;293(3):309-328. doi: 10.1111/joim.13593. Epub 2022 Dec 13.
鼻腔和鼻窦的促尿磷性间叶肿瘤:一种带来诊断挑战的临床罕见病例。
Auris Nasus Larynx. 2018 Apr;45(2):377-383. doi: 10.1016/j.anl.2017.05.006. Epub 2017 Jun 1.
4
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.镓-多柔比星用于肿瘤性骨软化症的肿瘤定位
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.
5
68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.68Ga DOTATATE PET/CT 是一种准确的影像学检查方法,可用于检测导致佝偻病的罪魁祸首肿瘤。
Clin Nucl Med. 2015 Aug;40(8):642-6. doi: 10.1097/RLU.0000000000000854.
6
Malignant phosphaturic mesenchymal tumor of the larynx.喉恶性磷酸尿基质肿瘤。
Laryngoscope. 2011 Sep;121(9):1860-3. doi: 10.1002/lary.21916. Epub 2011 Jun 30.
7
Tumor-induced osteomalacia.肿瘤相关性骨软化症。
Endocr Relat Cancer. 2011 Jun 8;18(3):R53-77. doi: 10.1530/ERC-11-0006. Print 2011 Jun.
8
Oncogenic osteomalacia of the cervical spine: a rare case of curative resection and reconstruction.颈椎骨母细胞瘤性骨软化症:一例罕见的治愈性切除与重建病例报告。
J Neurosurg Spine. 2011 Apr;14(4):453-6. doi: 10.3171/2010.11.SPINE09750. Epub 2011 Jan 28.
9
Case 165: Oncogenic osteomalacia.病例165:致癌性骨软化症。
Radiology. 2011 Jan;258(1):320-2. doi: 10.1148/radiol.10090702.
10
Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.磷调节素及其他新型介质对磷稳态的调节作用。
Pediatr Nephrol. 2008 Aug;23(8):1203-10. doi: 10.1007/s00467-008-0751-z. Epub 2008 Feb 21.